On the public citation graph
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
0 signed · 2893 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/j.1460-2075.1992.tb05481.xopenalex-snapshot
Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.
inferredcites →https://doi.org/10.1016/0008-8749(91)90091-oopenalex-snapshot
Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway
inferredcites →https://doi.org/10.1016/1074-7613(95)90125-6openalex-snapshot
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
inferredcites →https://doi.org/10.1016/s1074-7613(00)80089-8openalex-snapshot
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor
inferredcites →https://doi.org/10.1016/s1074-7613(00)80366-0openalex-snapshot
The Emerging Role of CTLA-4 as an Immune Attenuator
inferredcites →https://doi.org/10.1016/s1074-7613(00)80406-9openalex-snapshot
Lymphoproliferation in CTLA-4–Deficient Mice Is Mediated by Costimulation-Dependent Activation of CD4 + T Cells
inferredcites →https://doi.org/10.1038/332563a0openalex-snapshot
Localization of the binding site for the human high-affinity Fc receptor on IgG
inferredcites →https://doi.org/10.1038/70932openalex-snapshot
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
inferredcites →https://doi.org/10.1073/pnas.231486598openalex-snapshot
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine
inferredcites →https://doi.org/10.1084/jem.183.6.2533openalex-snapshot
CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.
inferredcites →https://doi.org/10.1084/jem.183.6.2541openalex-snapshot
CTLA-4 ligation blocks CD28-dependent T cell activation.
inferredcites →https://doi.org/10.1084/jem.191.5.891openalex-snapshot
Facilitation of β Selection and Modification of Positive Selection in the Thymus of Pd-1–Deficient Mice
inferredcites →https://doi.org/10.1084/jem.192.1.123openalex-snapshot
Failure to Suppress the Expansion of the Activated Cd4 T Cell Population in Interferon γ–Deficient Mice Leads to Exacerbation of Experimental Autoimmune Encephalomyelitis
inferredcites →https://doi.org/10.1084/jem.192.7.1027openalex-snapshot
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
inferredcites →https://doi.org/10.1093/intimm/10.10.1563openalex-snapshot
Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses
inferredcites →https://doi.org/10.1093/intimm/8.5.765openalex-snapshot
Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes
inferredcites →https://doi.org/10.1111/j.1600-065x.1998.tb01242.xopenalex-snapshot
The role of B7 co‐stimulation in activation and differentiation ofCD4+and CD8+T cells
inferredcites →https://doi.org/10.1126/science.270.5238.985openalex-snapshot
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
inferredcites →https://doi.org/10.1126/science.290.5495.1354openalex-snapshot
Regulation of Antigen-Specific CD8 + T Cell Homeostasis by Perforin and Interferon-γ
inferredcites →https://doi.org/10.1126/science.291.5502.319openalex-snapshot
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
inferredcites →https://doi.org/10.4049/jimmunol.160.5.2059openalex-snapshot
IFN-γ Is Critical for Long-Term Allograft Survival Induced by Blocking the CD28 and CD40 Ligand T Cell Costimulation Pathways
inferredcites →https://doi.org/10.4049/jimmunol.162.3.1270openalex-snapshot
Regulation of Cytotoxic T Lymphocyte-Associated Molecule-4 by Src Kinases
inferredcites →https://doi.org/10.4049/jimmunol.165.9.5035openalex-snapshot
Mouse Inducible Costimulatory Molecule (ICOS) Expression Is Enhanced by CD28 Costimulation and Regulates Differentiation of CD4+ T Cells
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4891960openalex-extracted
Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model
inferred← citeshttps://doi.org/10.1002/1521-4141(200202)32:2<366::aid-immu366>3.0.co;2-5openalex-snapshot
CTLA-4 regulates cell cycle progression during a primary immune response
inferred← citeshttps://doi.org/10.1002/1521-4141(200203)32:3<634::aid-immu634>3.0.co;2-9openalex-snapshot
PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
inferred← citeshttps://doi.org/10.1002/1521-4141(200211)32:11<3092::aid-immu3092>3.0.co;2-0openalex-snapshot
T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties
inferred← citeshttps://doi.org/10.1002/1873-3468.12045openalex-snapshot
Enhanced cytotoxic T‐cell function and inhibition of tumor progression by Mst1 deficiency
inferred← citeshttps://doi.org/10.1002/1878-0261.12032openalex-snapshot
Chemotherapy induces tumor immune evasion by upregulation of programmed cell death ligand 1 expression in bone marrow stromal cells
inferred← citeshttps://doi.org/10.1002/2211-5463.12865openalex-snapshot
CD279 mediates the homeostasis and survival of regulatory T cells by enhancing T cell and macrophage interactions
inferred← citeshttps://doi.org/10.1002/2211-5463.13102openalex-snapshot
Tislelizumab uniquely binds to the CC′ loop of PD‐1 with slow‐dissociated rate and complete PD‐L1 blockage
inferred← citeshttps://doi.org/10.1002/9781118345313.ch25openalex-snapshot
Co‐Administration of Co‐Stimulatory Moieties
inferred← citeshttps://doi.org/10.1002/9781118468791.ch29openalex-snapshot
Immunologic Approaches to Lung Cancer Therapy
inferred← citeshttps://doi.org/10.1002/9781118663387.ch8openalex-snapshot
Immune cell communication in liver disease and liver regeneration
inferred← citeshttps://doi.org/10.1002/9781118684535.ch14openalex-snapshot
T Cell Receptor Mimic Antibodies
inferred← citeshttps://doi.org/10.1002/9781118907474.ch54openalex-snapshot
Mesenchymal stromal cells for the treatment of autoimmune diseases
inferred← citeshttps://doi.org/10.1002/9781119432463.ch29openalex-snapshot
Programmed Death 1 ( PD 1)‐Mediated T ‐Cell Apoptosis and Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/9781119518495.ch21openalex-snapshot
Adjuvant Therapy options after Pelvic Exenteration for Advanced Rectal Cancer
inferred← citeshttps://doi.org/10.1002/9783527619696.ch30openalex-snapshot
Pharmacologically Modified Dendritic Cells: A Route to Tolerance‐associated Genes
inferred← citeshttps://doi.org/10.1002/aac2.12045openalex-snapshot
Immune checkpoint expression and relationships to anti‐PD‐L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice
inferred← citeshttps://doi.org/10.1002/adfm.202006220openalex-snapshot
Macrophage‐Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention
inferred← citeshttps://doi.org/10.1002/adfm.202107540openalex-snapshot
Immune Cycle‐Based Strategies for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/adhm.201800987openalex-snapshot
BTNL2‐Ig Protein Attenuates Type 1 Diabetes in Non‐Obese Diabetic (NOD) Mice
inferred← citeshttps://doi.org/10.1002/advs.202207108openalex-snapshot
The Oxysterol Receptor EBI2 Links Innate and Adaptive Immunity to Limit IFN Response and Systemic Lupus Erythematosus
inferred← citeshttps://doi.org/10.1002/advs.202400702openalex-snapshot
Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders
inferred← citeshttps://doi.org/10.1002/advs.202400747openalex-snapshot
Immune Checkpoint PD‐L1 Modulates Retinal Microglial Activation to Alleviate Vascular Leakage in Choroidal Neovascularization via ERK
inferred← citeshttps://doi.org/10.1002/ajh.26461openalex-snapshot
PD‐L1 overexpression correlates with JAK2‐V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms
inferred← citeshttps://doi.org/10.1002/ana.20514openalex-snapshot
A PD‐1 polymorphism is associated with disease progression in multiple sclerosis
inferred← citeshttps://doi.org/10.1002/ana.20662openalex-snapshot
The adaptive immune response in neonatal cerebral white matter damage
inferred← citeshttps://doi.org/10.1002/art.20040openalex-snapshot
Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus
inferred← citeshttps://doi.org/10.1002/art.20966openalex-snapshot
A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese
inferred← citeshttps://doi.org/10.1002/art.27500openalex-snapshot
The programmed death 1/programmed death ligand 1 inhibitory pathway is up‐regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis
inferred← citeshttps://doi.org/10.1002/art.40164openalex-snapshot
Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis
inferred← citeshttps://doi.org/10.1002/cam4.106openalex-snapshot
PD ‐1 as a potential target in cancer therapy
inferred← citeshttps://doi.org/10.1002/cam4.1929openalex-snapshot
Prognostic significance of PD‐L2 expression in patients with oral squamous cell carcinoma—A comparison to the PD‐L1 expression profile
inferred← citeshttps://doi.org/10.1002/cam4.5386openalex-snapshot
Tumor immune microenvironment in therapy‐naive esophageal adenocarcinoma could predict the nodal status
inferred← citeshttps://doi.org/10.1002/cam4.6053openalex-snapshot
Immune‐check blocking combination multiple cytokines shown curative potential in mice tumor model
inferred← citeshttps://doi.org/10.1002/cam4.6330openalex-snapshot
Identification of age‐ and immune‐related gene signatures for clinical outcome prediction in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1002/cam4.6455openalex-snapshot
Association of immune checkpoint inhibitors therapy with arterial thromboembolic events in cancer patients: A retrospective cohort study
inferred← citeshttps://doi.org/10.1002/cam4.70960openalex-snapshot
Clinical Implications of Mismatch Repair Deficiency in Pancreatic Ductal Adenocarcinoma
inferred← citeshttps://doi.org/10.1002/cbin.10024openalex-snapshot
Expression and biological function of programmed death ligands in human placenta mesenchymal stem cells
inferred← citeshttps://doi.org/10.1002/ccr3.6050openalex-snapshot
Genomic and immune microenvironment profiling in a case of metastatic intrathyroid thymic carcinoma
inferred← citeshttps://doi.org/10.1002/cjp2.81openalex-snapshot
Histopathological and genotypic characterization of metastatic colorectal carcinoma with PD‐L1 (CD274)‐expression: Possible roles of tumour micro environmental factors for CD274 expression
inferred← citeshttps://doi.org/10.1002/cmdc.202000760openalex-snapshot
The Stone Guest: How Does pH Affect Binding Properties of PD‐1/PD‐L1 Inhibitors?
inferred← citeshttps://doi.org/10.1002/cncr.25747openalex-snapshot
Overall survival and PD‐L1 expression in metastasized malignant melanoma
inferred← citeshttps://doi.org/10.1002/cncr.31751openalex-snapshot
First person: Arlene Sharpe, MD, PhD
inferred← citeshttps://doi.org/10.1002/cncr.33424openalex-snapshot
Immunotherapy and radiation therapy sequencing: State of the data on timing, efficacy, and safety
inferred← citeshttps://doi.org/10.1002/cncr.33690openalex-snapshot
A phase 1b/2 study of azacitidine with PD‐L1 antibody avelumab in relapsed/refractory acute myeloid leukemia
inferred← citeshttps://doi.org/10.1002/cnr2.1160openalex-snapshot
Soluble immune checkpoint molecules: Serum markers for cancer diagnosis and prognosis
inferred← citeshttps://doi.org/10.1002/cre2.477openalex-snapshot
Tumor‐infiltrating FoxP3 + T cells are associated with poor prognosis in oral squamous cell carcinoma
inferred← citeshttps://doi.org/10.1002/cti2.1071openalex-snapshot
Crohn's disease is facilitated by a disturbance of programmed death‐1 ligand 2 on blood dendritic cells
inferred← citeshttps://doi.org/10.1002/cti2.1076openalex-snapshot
The role and therapeutic implications of T cells in cancer of the lung
inferred← citeshttps://doi.org/10.1002/ctm2.37openalex-snapshot
Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints
inferred← citeshttps://doi.org/10.1002/ctm2.70061openalex-snapshot
Single‐cell transcriptome analysis reveals evolving tumour microenvironment induced by immunochemotherapy in nasopharyngeal carcinoma
inferred← citeshttps://doi.org/10.1002/cyto.a.22808openalex-snapshot
OMIP ‐031: Immunologic checkpoint expression on murine effector and memory T ‐cell subsets
inferred← citeshttps://doi.org/10.1002/cyto.a.22983openalex-snapshot
OMIP‐037: 16‐color panel to measure inhibitory receptor signatures from multiple human immune cell subsets
inferred← citeshttps://doi.org/10.1002/dmrr.345openalex-snapshot
Negative T cell costimulation and islet tolerance
inferred← citeshttps://doi.org/10.1002/eji.200324084openalex-snapshot
Preferential contribution of B7‐H1 to programmed death‐1‐mediated regulation of hapten‐specific allergic inflammatory responses
inferred← citeshttps://doi.org/10.1002/eji.200324228openalex-snapshot
Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses
inferred← citeshttps://doi.org/10.1002/eji.200324270openalex-snapshot
Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8+ T cell activation and cytolysis
inferred← citeshttps://doi.org/10.1002/eji.200425197openalex-snapshot
Paradoxical role of programmed death‐1 ligand 2 in Th2 immune responses in vitro and in a mouse asthma model in vivo
inferred← citeshttps://doi.org/10.1002/eji.200425227openalex-snapshot
Frontline: Characterization of BT3 molecules belonging to the B7 family expressed on immune cells
inferred← citeshttps://doi.org/10.1002/eji.200425388openalex-snapshot
Commentary: Regulated equilibrium between opposite signals: a general paradigm for T cell function?
inferred← citeshttps://doi.org/10.1002/eji.200425405openalex-snapshot
Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway
inferred← citeshttps://doi.org/10.1002/eji.200526231openalex-snapshot
Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Toll-like receptor 9 ligand
inferred← citeshttps://doi.org/10.1002/eji.200526347openalex-snapshot
PD‐L2:PD‐1 involvement in T cell proliferation, cytokine production, and integrin‐mediated adhesion
inferred← citeshttps://doi.org/10.1002/eji.200535232openalex-snapshot
Antibody‐mediated signaling through PD‐1 costimulates T cells and enhances CD28‐dependent proliferation
inferred← citeshttps://doi.org/10.1002/eji.200535344openalex-snapshot
No evidence for dualism in function and receptors: PD‐L2/B7‐DC is an inhibitory regulator of human T cell activation
inferred← citeshttps://doi.org/10.1002/eji.200535458openalex-snapshot
PD‐L1 and PD‐L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis
inferred← citeshttps://doi.org/10.1002/eji.200635978openalex-snapshot
Contribution of the PD‐1 ligands/PD‐1 signaling pathway to dendritic cell‐mediated CD4 + T cell activation
inferred← citeshttps://doi.org/10.1002/eji.200636031openalex-snapshot
Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function
inferred← citeshttps://doi.org/10.1002/eji.200636240openalex-snapshot
The tyrosine phosphatase SHP‐2 regulates differentiation and apoptosis of individual primary T lymphocytes
inferred← citeshttps://doi.org/10.1002/eji.200737461openalex-snapshot
PD‐L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for VH11/VH12 and phosphatidylcholine binding
inferred← citeshttps://doi.org/10.1002/eji.200737583openalex-snapshot
Programmed cell death 1 (PD‐1) and its ligand PD‐L1 are required for allograft tolerance
inferred← citeshttps://doi.org/10.1002/eji.200738071openalex-snapshot
B7‐H1 restricts neuroantigen‐specific T cell responses and confines inflammatory CNS damage: Implications for the lesion pathogenesis of multiple sclerosis
inferred← citeshttps://doi.org/10.1002/eji.200838137openalex-snapshot
PD‐1 ligands expressed on myeloid‐derived APC in the CNS regulate T‐cell responses in EAE
inferred← citeshttps://doi.org/10.1002/eji.200838990openalex-snapshot
The DC‐HIL/syndecan‐4 pathway inhibits human allogeneic T‐cell responses
inferred← citeshttps://doi.org/10.1002/eji.200839028openalex-snapshot
B7‐H3 is a potent inhibitor of human T‐cell activation: No evidence for B7‐H3 and TREML2 interaction
inferred← citeshttps://doi.org/10.1002/eji.200839103openalex-snapshot
Induction of Treg by monocyte‐derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD‐L1
inferred← citeshttps://doi.org/10.1002/eji.201040959openalex-snapshot
Expression and function of PD‐1 in human γδ T cells that recognize phosphoantigens
inferred← citeshttps://doi.org/10.1002/eji.201141639openalex-snapshot
Anti‐PD‐1 synergizes with cyclophosphamide to induce potent anti‐tumor vaccine effects through novel mechanisms
inferred← citeshttps://doi.org/10.1002/eji.201141931openalex-snapshot
Reduced tumor‐antigen density leads to PD‐1/PD‐L1‐mediated impairment of partially exhausted CD8+ T cells
inferred← citeshttps://doi.org/10.1002/eji.201190035openalex-snapshot
Cancer immunotherapy: Progress and challenges in the clinical setting
inferred← citeshttps://doi.org/10.1002/eji.201242501openalex-snapshot
Intact B 7‐ H 3 signaling promotes allograft prolongation through preferential suppression of T h1 effector responses
inferred← citeshttps://doi.org/10.1002/eji.201444778openalex-snapshot
Differential control of CD4+ T‐cell subsets by the PD‐1/PD‐L1 axis in a mouse model of allergic asthma
inferred← citeshttps://doi.org/10.1002/eji.201646875openalex-snapshot
Immune checkpoints and their inhibition in cancer and infectious diseases
inferred← citeshttps://doi.org/10.1002/eji.202048747openalex-snapshot
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action
inferred← citeshttps://doi.org/10.1002/ejp.513openalex-snapshot
Intrathecal administration of botulinum toxin type A improves urinary bladder function and reduces pain in rats with cystitis
inferred← citeshttps://doi.org/10.1002/gcc.22365openalex-snapshot
Pan‐cancer analysis of copy number changes in programmed death‐ligand 1 (PD‐L1, CD274) – associations with gene expression, mutational load, and survival
inferred← citeshttps://doi.org/10.1002/hep.20494openalex-snapshot
Biliary epithelial cells regulate autoreactive T cells: Implications for biliary-specific diseases
inferred← citeshttps://doi.org/10.1002/hep.21060openalex-snapshot
The Liver as an Immunological Organ
inferred← citeshttps://doi.org/10.1002/hep.21965openalex-snapshot
Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance
inferred← citeshttps://doi.org/10.1002/hep.23173openalex-snapshot
Chronically inflamed livers up-regulate expression of inhibitory B7 family members #
inferred← citeshttps://doi.org/10.1002/hep.27246openalex-snapshot
Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future directions
inferred← citeshttps://doi.org/10.1002/hep.29360openalex-snapshot
Programmed cell death‐1 (PD‐1) checkpoint blockade in combination with a mammalian target of rapamycin inhibitor restrains hepatocellular carcinoma growth induced by hepatoma cell–intrinsic PD‐1
inferred← citeshttps://doi.org/10.1002/hon.2098openalex-snapshot
Programmed death 1 and B and T lymphocyte attenuator immunoreceptors and their association with malignant T‐lymphoproliferative disorders: brief review
inferred← citeshttps://doi.org/10.1002/iid3.394openalex-snapshot
Serum soluble PD‐1 plays a role in predicting infection complications in patients with acute pancreatitis
inferred← citeshttps://doi.org/10.1002/ijc.1503openalex-snapshot
Active immunization against cancer with dendritic cells: The near future
inferred← citeshttps://doi.org/10.1002/ijc.21775openalex-snapshot
Blockade of PD‐L1 (B7‐H1) augments human tumor‐specific T cell responses in vitro
inferred← citeshttps://doi.org/10.1002/ijc.23042openalex-snapshot
Augmented expression of programmed death‐1 in both neoplastic and non‐neoplastic CD4+ T‐cells in adult T‐cell leukemia/lymphoma
inferred← citeshttps://doi.org/10.1002/ijc.26272openalex-snapshot
PD‐1 expression on Melan‐A‐reactive T cells increases during progression to metastatic disease
inferred← citeshttps://doi.org/10.1002/ijc.33415openalex-snapshot
Targeting CTLA ‐4 in cancer: Is it the ideal companion for PD ‐1 blockade immunotherapy combinations?
inferred← citeshttps://doi.org/10.1002/inmd.20230025openalex-snapshot
Anti‐angiogenic therapy enhances cancer immunotherapy: Mechanism and clinical application
inferred← citeshttps://doi.org/10.1002/iub.208openalex-snapshot
Structural immunology and crystallography help immunologists see the immune system in action: How T and NK cells touch their ligands
inferred← citeshttps://doi.org/10.1002/jbm.a.36155openalex-snapshot
Characterization of poly(L‐glutamic acid)‐grafted hyaluronan as a novel candidate medicine and biomedical device for intra‐articular injection
inferred← citeshttps://doi.org/10.1002/jcp.27172openalex-snapshot
PD‐1/PD‐L1 immune checkpoint: Potential target for cancer therapy
inferred← citeshttps://doi.org/10.1002/jcp.28181openalex-snapshot
Immune therapy of melanoma: Overview of therapeutic vaccines
inferred← citeshttps://doi.org/10.1002/jcp.28358openalex-snapshot
PD‐1/PD‐L1 pathway: Basic biology and role in cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/jcp.29494openalex-snapshot
PD‐1/PD‐L1‐dependent immune response in colorectal cancer
inferred← citeshttps://doi.org/10.1002/jcp.30197openalex-snapshot
Tumor‐derived exosomes in the PD‐1/PD‐L1 axis: Significant regulators as well as promising clinical targets
inferred← citeshttps://doi.org/10.1002/jlb.1mr0420-003rropenalex-snapshot
The role of B7 family members in the generation of Immunoglobulin
inferred← citeshttps://doi.org/10.1002/jlb.1ri0121-066ropenalex-snapshot
A review of signaling and transcriptional control in T follicular helper cell differentiation
inferred← citeshttps://doi.org/10.1002/jlb.2mir0917-377ropenalex-snapshot
A novel role for coinhibitory receptors/checkpoint proteins in the immunopathology of sepsis
inferred← citeshttps://doi.org/10.1002/jlb.4cova0122-076ropenalex-snapshot
Single-cell immune profiling reveals long-term changes in myeloid cells and identifies a novel subset of CD9+ monocytes associated with COVID-19 hospitalization
inferred← citeshttps://doi.org/10.1002/jlb.6ma0921-752rropenalex-snapshot
Stem cells from exfoliated deciduous teeth transplantation ameliorates Sjögren's syndrome by secreting soluble PD-L1
inferred← citeshttps://doi.org/10.1002/jmv.23289openalex-snapshot
Study of CD4+CD8+ Double positive T‐lymphocyte phenotype and function in Indian patients infected with HIV‐1
inferred← citeshttps://doi.org/10.1002/jmv.71090openalex-snapshot
Investigation of PDCD1 Gene Polymorphisms and Haplotypes in COVID‐19 Severity and Outcome in a Brazilian Population
inferred← citeshttps://doi.org/10.1002/jnr.20881openalex-snapshot
Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of treg cells, and enhanced expression of the PD-1 costimulatory pathway
inferred← citeshttps://doi.org/10.1002/jso.23281openalex-snapshot
Increased PD‐1 expression on CD4+ and CD8+ T cells is involved in immune evasion in gastric cancer
inferred← citeshttps://doi.org/10.1002/jso.24266openalex-snapshot
Programmed death ligand‐1 expression is associated with poor disease free survival in salivary gland carcinomas
inferred← citeshttps://doi.org/10.1002/jso.26312openalex-snapshot
Immunotherapy for pancreatic ductal adenocarcinoma
inferred← citeshttps://doi.org/10.1002/jso.27725openalex-snapshot
Expression of CD28, FAS, PD1, and CTLA4 molecules in the blood of women with triple‐negative breast cancer
inferred← citeshttps://doi.org/10.1002/kjm2.12375openalex-snapshot
Mechanisms of immunogenic cell death and immune checkpoint blockade therapy
inferred← citeshttps://doi.org/10.1002/med.20243openalex-snapshot
Antigen‐specific blocking of CD4‐Specific immunological synapse formation using BPI and current therapies for autoimmune diseases
inferred← citeshttps://doi.org/10.1002/med.21478openalex-snapshot
Potential cardiac risk of immune‐checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects
inferred← citeshttps://doi.org/10.1002/med.21530openalex-snapshot
Immunomodulators targeting the PD‐1/PD‐L1 protein‐protein interaction: From antibodies to small molecules
inferred← citeshttps://doi.org/10.1002/med.21876openalex-snapshot
Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets
inferred← citeshttps://doi.org/10.1002/mog2.8openalex-snapshot
Tumor immunotherapy: Mechanisms and clinical applications
inferred← citeshttps://doi.org/10.1002/path.5038openalex-snapshot
Established, emerging and elusive molecular targets in the treatment of lung cancer
inferred← citeshttps://doi.org/10.1002/pbc.25284openalex-snapshot
The role of programmed cell death‐1 (PD‐1) and its ligands in pediatric cancer
inferred← citeshttps://doi.org/10.1002/pbc.30110openalex-snapshot
The tumor microenvironment and immune targeting therapy in pediatric renal tumors
inferred← citeshttps://doi.org/10.1002/pro.70268openalex-snapshot
Using extension‐based mRNA display to design antibody‐like proteinogenic peptides for human PD ‐ L1
inferred← citeshttps://doi.org/10.1002/ptr.8185openalex-snapshot
Promising natural products targeting protein tyrosine phosphatase SHP2 for cancer therapy
inferred← citeshttps://doi.org/10.1002/rmv.2094openalex-snapshot
Expressions of inhibitory checkpoint molecules in acute and chronic HBV and HCV infections: Implications for therapeutic monitoring and personalized therapy
inferred← citeshttps://doi.org/10.1002/stem.1387openalex-snapshot
Periodontal Ligament Stem Cells Regulate B Lymphocyte Function via Programmed Cell Death Protein 1
inferred← citeshttps://doi.org/10.1006/clim.2001.5093openalex-snapshot
Costimulation of Memory T-Cells by ICOS: A Potential Therapeutic Target for Autoimmunity?
inferred← citeshttps://doi.org/10.1006/clim.2002.5277openalex-snapshot
A Cell-Based Artificial Antigen-Presenting Cell Coated with Anti-CD3 and CD28 Antibodies Enables Rapid Expansion and Long-Term Growth of CD4 T Lymphocytes
inferred← citeshttps://doi.org/10.1007/0-387-34944-8_15openalex-snapshot
B7 Family Molecules in the Placenta
inferred← citeshttps://doi.org/10.1007/164_2019_323openalex-snapshot
Monoclonal Antibodies: Past, Present and Future
inferred← citeshttps://doi.org/10.1007/16833_2022_63openalex-snapshot
The Use of Immunotherapy in Cancer Patients with Autoimmune Diseases
inferred← citeshttps://doi.org/10.1007/16833_2024_258openalex-snapshot
Immune Checkpoint Inhibitors: Novel Therapies and Targets
inferred← citeshttps://doi.org/10.1007/82_2010_116openalex-snapshot
Role of PD-1 in Regulating T-Cell Immunity
inferred← citeshttps://doi.org/10.1007/82_2010_81openalex-snapshot
Immunobiology of Cancer Therapies Targeting CD137 and B7-H1/PD-1 Cosignal Pathways
inferred← citeshttps://doi.org/10.1007/82_2017_67openalex-snapshot
Role of PD-1 in Immunity and Diseases
inferred← citeshttps://doi.org/10.1007/82_2017_68openalex-snapshot
Mining the Complex Family of Protein Tyrosine Phosphatases for Checkpoint Regulators in Immunity
inferred← citeshttps://doi.org/10.1007/978-0-387-36003-4_7openalex-snapshot
Co-stimulation Regulation of Immune Tolerance and Autoimmunity
inferred← citeshttps://doi.org/10.1007/978-0-387-69118-3_3openalex-snapshot
Contribution of B7-H1/PD-1 Co-inhibitory Pathway to T-Cell Dysfunction in Cancer
inferred← citeshttps://doi.org/10.1007/978-1-0716-0377-2_24openalex-snapshot
Systemic Therapy for Esophageal Squamous Cell Carcinoma
inferred← citeshttps://doi.org/10.1007/978-1-0716-0741-1_3openalex-snapshot
Immune System, Inflammation, and Essential Fatty Acids and Their Metabolites in Cancer
inferred← citeshttps://doi.org/10.1007/978-1-0716-0849-4_14openalex-snapshot
High-Dimensional Flow Cytometry Analysis of Regulatory Receptors on Human T Cells, NK Cells, and NKT Cells
inferred← citeshttps://doi.org/10.1007/978-1-4020-6087-8openalex-snapshot
General Principles of Tumor Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-1-4020-6087-8_3openalex-snapshot
T Cells and Antigen Recognition
inferred← citeshttps://doi.org/10.1007/978-1-4419-8999-4_16openalex-snapshot
Costimulatory Molecules in T CeII Activation and Transplantation
inferred← citeshttps://doi.org/10.1007/978-1-4419-9914-6_14openalex-snapshot
Cell Surface Co-signaling Molecules in the Control of Innate and Adaptive Cancer Immunity
inferred← citeshttps://doi.org/10.1007/978-1-4614-0484-2_7openalex-snapshot
Modulation of T-Cell Mediated Immunity by Cytomegalovirus
inferred← citeshttps://doi.org/10.1007/978-1-4614-4732-0_8openalex-snapshot
Immune Co-signaling to Treat Cancer
inferred← citeshttps://doi.org/10.1007/978-1-4614-7147-9_22openalex-snapshot
Side Effects of Systemic Therapy and Their Clinical Management
inferred← citeshttps://doi.org/10.1007/978-1-4614-7322-0_22-1openalex-snapshot
Side Effects of Systemic Therapy and Their Clinical Management
inferred← citeshttps://doi.org/10.1007/978-1-4939-2724-1_7openalex-snapshot
Inflammation and Lung Cancer: Addressing Inflammation with Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-1-4939-6548-9_6openalex-snapshot
Phenotypic and Functional Analysis of Antigen-Specific T Cell Exhaustion
inferred← citeshttps://doi.org/10.1007/978-1-4939-8958-4_4openalex-snapshot
Monoclonal Antibodies for the Treatment of Melanoma: Present and Future Strategies
inferred← citeshttps://doi.org/10.1007/978-1-4939-9773-2_2openalex-snapshot
Immunological Targets for Immunotherapy: Inhibitory T Cell Receptors
inferred← citeshttps://doi.org/10.1007/978-1-59745-035-5_31openalex-snapshot
Tumor Immune Escape Mechanisms
inferred← citeshttps://doi.org/10.1007/978-1-59745-332-5_21openalex-snapshot
Restoring Host Antitumoral Immunity: How Coregulatory Molecules Are Changing the Approach to the Management of Renal Cell Carcinoma
inferred← citeshttps://doi.org/10.1007/978-1-59745-470-4_15openalex-snapshot
Harnessing the Power of Immunity to Battle Cancer: Much Ado about Nothing or All's Well That Ends Well?
inferred← citeshttps://doi.org/10.1007/978-1-59745-517-6_2openalex-snapshot
Immunogenetic Factors in Autoimmunity
inferred← citeshttps://doi.org/10.1007/978-1-60327-087-8_48openalex-snapshot
Targeting Immunological Synapse: New Horizons in Immunotherapy for Cancer
inferred← citeshttps://doi.org/10.1007/978-1-60761-588-0_21openalex-snapshot
Inhibitory RNA Molecules in Immunotherapy for Cancer
inferred← citeshttps://doi.org/10.1007/978-1-60761-869-0_26openalex-snapshot
Organ Transplantation: Modulation of T-Cell Activation Pathways Initiated by Cell Surface Receptors to Suppress Graft Rejection
inferred← citeshttps://doi.org/10.1007/978-1-62703-062-5_16openalex-snapshot
Immunotherapy for Renal Cell Carcinoma
inferred← citeshttps://doi.org/10.1007/978-3-030-02505-2_6openalex-snapshot
Immune-Related Adverse Events: Pneumonitis
inferred← citeshttps://doi.org/10.1007/978-3-030-15935-1_5openalex-snapshot
Innate and Adaptive Immune Responses to Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-16792-9_36openalex-snapshot
Immunotherapy in Breast Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-18797-2_2openalex-snapshot
Non-melanoma Skin Cancer and Cutaneous Melanoma from the Oncological Point of View
inferred← citeshttps://doi.org/10.1007/978-3-030-22254-3_17openalex-snapshot
Small Molecule Inhibition of Glycogen Synthase Kinase-3 in Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-030-41008-7_13openalex-snapshot
Immune-Related Adverse Events: Pneumonitis
inferred← citeshttps://doi.org/10.1007/978-3-030-50224-9_1openalex-snapshot
MicroRNAs in the Tumor Microenvironment
inferred← citeshttps://doi.org/10.1007/978-3-030-50287-4_6openalex-snapshot
Overcoming Cancer Tolerance with Immune Checkpoint Blockade
inferred← citeshttps://doi.org/10.1007/978-3-030-50668-1_37openalex-snapshot
Immunotherapy and Radiosurgery
inferred← citeshttps://doi.org/10.1007/978-3-030-71113-9_39-1openalex-snapshot
Principles of Immunotherapy and Novel Immunotherapeutic Agents for Pediatric Cancer Management
inferred← citeshttps://doi.org/10.1007/978-3-030-79308-1_14openalex-snapshot
Pulmonary Toxicities of Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-030-79308-1_9openalex-snapshot
An Update on Immune Based Therapies in Acute Myeloid Leukemia: 2021 and Beyond!
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_174-1openalex-snapshot
Immune Checkpoint Inhibitors in Gastroesophageal Junction or Gastric Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_176-1openalex-snapshot
Shaping of the Clinical Landscape of Immunotherapy by PD-L1 Expression in Breast Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_178-1openalex-snapshot
Checkpoint Blockade in Hematologic Malignancies
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_179-1openalex-snapshot
Predictive Factors for Response and Resistance to Anti-PD-1 Immunotherapy in Melanoma
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_218-1openalex-snapshot
Immunotherapy in Gastrointestinal Malignancies
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_218-2openalex-snapshot
Immunotherapy for Gastrointestinal Malignancies
inferred← citeshttps://doi.org/10.1007/978-3-030-96376-7_2openalex-snapshot
Melanoma: An immunotherapy journey from bench to bedside
inferred← citeshttps://doi.org/10.1007/978-3-031-06566-8_15openalex-snapshot
AKT Isoforms in the Immune Response in Cancer
inferred← citeshttps://doi.org/10.1007/978-3-031-40901-1_10openalex-snapshot
Prognostic Factors in Advanced Renal Cell Carcinoma
inferred← citeshttps://doi.org/10.1007/978-3-031-72079-6_15openalex-snapshot
Alexithymia and Immunity: More Than 50 years Later, Where Do We Stand?
inferred← citeshttps://doi.org/10.1007/978-3-031-76882-8_39openalex-snapshot
Principles of Immunotherapy and Novel Immunotherapeutic Agents for Pediatric Cancer Management
inferred← citeshttps://doi.org/10.1007/978-3-031-90598-8_15openalex-snapshot
Immune Checkpoint Inhibitors and Myocarditis: Clinical Impact and Underlying Mechanisms
inferred← citeshttps://doi.org/10.1007/978-3-031-97242-3_7openalex-snapshot
Immunotherapy in Head and Neck Cancer
inferred← citeshttps://doi.org/10.1007/978-3-032-00765-0_174openalex-snapshot
Immune Checkpoint Inhibitors in Gastroesophageal Junction or Gastric Cancer
inferred← citeshttps://doi.org/10.1007/978-3-032-00765-0_176openalex-snapshot
Shaping of the Clinical Landscape of Immunotherapy by PD-L1 Expression in Breast Cancer
inferred← citeshttps://doi.org/10.1007/978-3-032-00765-0_178openalex-snapshot
Checkpoint Blockade in Hematologic Malignancies
showing the first 200 of 2870 · page through all 2870
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.